REGISTRATION CONFIRMATION
Thank you for registering for our RCC TeleECHO Session. Please see program details below. Login information is provided below and will also be sent to you via the email you provided during registration. Please extend the invite to your colleagues.
Insights to Manage Renal Cell Carcinoma with First-line Immuno-oncology/Tyrosine Kinase Inhibitor Combination Therapies: Which of Your Patients Can Benefit?
Tuesday, April 27, 2021
12:00PM – 1:00PM ET
Please note this TeleECHO program is 12:00PM Eastern, 11:00AM, Central, 10:00AM Mountain and 9:00AM Pacific.
You can find more information about this program at https://www.medlearninggroup.com/cme-programming/rcc-echo3/
Register a colleague at https://www.medlearninggroup.com/cme-programming/rcc-echo3-registration/
1) PARTICIPATE
LOGIN INFORMATION:
Join Zoom Meeting
https://us02web.zoom.us/j/86856496409
Meeting ID: 868 5649 6409
One tap mobile
+13462487799,,86856496409# US (Houston)
+16699006833,,86856496409# US (San Jose)
Dial by your location
+1 346 248 7799 US (Houston)
+1 669 900 6833 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 312 626 6799 US (Chicago)
+1 929 205 6099 US (New York)
+1 301 715 8592 US (Washington DC)
Meeting ID: 868 5649 6409
Find your local number: https://us02web.zoom.us/u/kfcWiyUVo
Should you have any questions or concerns, please contact us at any time.
Sincerely,
Joseph L. Guerriero, MBA
Director of Educational Solutions
Med Learning Group
450 7th Avenue, 32nd Floor
New York, NY 10123
[email protected]
www.medlearninggroup.com